BIT's 2nd Symposium on Enzymes & Biocatalysis-2011 (SEB-2011), successfully held in Dalian World Expo Center on April 25-30, 2011. Totally, there were nearly 300 participants from more than 30 countries and areas have attended the seb-2011.
As the keynote speakers, Dr. Wenping Wu, Senior Director, R&D Center, Novozymes China, China; Dr. Mani Subramanian, Professor, Chemical & Biochemical Engineering; Director, Center for Biocatalysis & Bioprocessing, The University of Iowa, USA; Dr. John H. Dawson, Carolina Distinguished Professor, Department of Chemistry and Biochemistry, University of South Carolina, USA and Dr. Russ Hille, Professor, Department of Biochemistry, University of California, USA made excellent presentations and warmly discussed with the audiences at keynote forum.
18 sessions covered 9 fields including Emerging Research on Enzymes, Enzyme Titer and Activity Improvement, Enzymes and Biocatalysis in Pharmaceutical Industries, Applied Industrial Enzymes, Basic Research on Biocatalysis, Biocatalysis in Organic Chemistry and Molecular Synthesis, Enzymes in Environment, Bioremediation and Bioaugmentation, Biocatalysis and Biocatalytic Technologies, Alternative Applications of Biocatalysis and so on. With the mission to initiate a sustainable platform for exchanging up-to-the-minute upstream and downstream achievements, industrial needs and research opportunities of industrial biotechnology fields in Asia Pacific Rim, participants from academic, industrial professionals and key-decision makers delivered the new achievement on their research, together discussed and analyzed the development of Enzymes and Biocatalysis. The conference has promoted the communication of colleagues and collaboration of partners from the upstream to the downstream of Enzymes and Biocatalysis.
Depending on the warmly support and good suggestions from all of the participants, we are confident in organizing seb-2012 which would be better and more successful than seb-2011.
Nobel Prize Laureates You can click each laureate’s photo to see: (Supporting Documentation: Confirmation Letter from Nobel Prize Laureates)
The “Nobel Across China Program” encourages young scientists to learn the latest discoveries in their fields. It encourages information exchanges in order to support research in life sciences between China and the rest of the world
Title : Towards a Structural Understanding of How DNA is Replicated into DNA and Transcribed into RNA Dr.Thomas A.Steitz,
The Nobel Prize Laureate
in Chemistry 2009
Title : The Ribosome- an Amazing Machine for Translating the Genetic Dr.Ada E.Yonath,
The Nobel Prize Laureate
in Chemistry 2009
Title : Two Extraordinary Proteins
Learned from Nature:
The Green Fluorescent Protein
GFP and the Photoprotein
Aequorin Dr. Osamu Shimomura,
The Nobel Prize Laureate
in Chemistry 2008
Title : The Other Side of the Gene: Protein Degradation – Physiology, Human Diseases, and Drug Targeting Dr.Aaron Ciechanover,
The Nobel Prize Laureate
in Chemistry 2004
Title : The Ubiquitin System in Health and Disease Dr.Avram Hershko,
The Nobel Prize Laureate
in Chemistry 2004
Title : Switches and Latches: The Control of Cell Division Dr.Tim Hunt,
The Nobel Prize Laureate
in Physiology
or Medicine 2001
Title : The Looming Crisis in the World's Helium Supply Dr. Robert C. Richardson,
The Nobel Prize Laureate in Physics 1996, Professor, Senior Vice Provost for Research, Cornell University, USA
Title : 60 Years of DNA Dr. Richard Roberts,
The Nobel Prize Laureate in Physiology or Medicine 1993, Chief Scientific Officer, New England Biolabs, USA
Title : Function of Proteins Involved in Neurotransmitter Release and Short-term Synaptic Plasticity Dr. Erwin Neher,
Nobel Prize Laureate in Physiology or Medicine 1991, Director of the Max Planck Institute for Biophysical Chemistry, Germany
More Under Coordination
News Release
Welcome the delegates from Arizona State University, USA
[2010-11-15]
Welcome the delegates from University of Wisconsin, USA
[2010-11-15]
Welcome the delegates from TU Bergakademie Freiberg, Germany
[2010-11-8]
Welcome the delegates from Seoul National University, South Korea
[2010-11-8]
Welcome the delegates from University College Cork, Ireland
SEB-2010 was successfully held during April 22-24, 2010 in Shanghai, China. Altogether, 500 participants from 48 countries and regions participated in the conference. Dr. Wenping Wu, Director, R&D China, Novozymes China; Dr. Wenying Li, Principal Scientist, Bristol-Myers Squibb Co., USA; Dr. Yijun Chen, Endowed Professor and Director, Laboratory of Chemical Biology, China Pharmaceutical University, China; Dr. Xiaodan Mei, President, BITeomics, Inc., China gave wonderful keynote speeches respectively during the conference.More...
Exhibition and Poster
SEB-2011 provides an ideal platform to showcase your novel technologies and products in China. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.
Why Reserve a Booth at SEB-2011
To Meet Face-to-Face with the International Movers and Shakers in the Field of Enzymes and Biocatalysts
To Meet with Key Decision Marker around the World
To Explore Business Opportunities in China and beyond
To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition Hall
Arnold L. Demain, Member of the National Academy of Sciences in The United States, Founder of Dep. of Fermentation Microbiology at Merck & Co., Inc., Professor, Drew University, USA
Dr. Wenping Wu,
Director, R&D China, Novozymes China
Dr. Theo Sonke,
Senior Scientist, DSM Pharmaceutical Products, The Netherlands
Dr. Eliora Z. Ron,
Chair Elect of BAM section of IUMS, International Union of Microbiological Societies), Professor of Microbiology, Faculty of Life Sciences, Tel Aviv University, Israel
Dr. Hans R Herren, President, Millennium Institute, USA
Dr. Jane Dyson, Professor, The Scripps Research Institute, USA
Dr. Mani Subramanian, Professor, Chemical & Biochemical Engineering; Director, Center for Biocatalysis & Bioprocessing, The University of Iowa, USA
Dr. Mark Emalfarb, President, Dyadic International, USA
Dr. Nicholas J Turner, Professor, Chemical Biology and Director of the Centre of Excellence in Biocatalysis (CoEBio3), Manchester Interdisciplinary Biocentre, UK
Dr. Sunney Chan, Academician, Distinguished Research Fellow and Former Vice President of Academia Sinica, Taiwan; George Grant Hoag Professor Emeritus, California Institute of Technology, USA
Dr. Peter SeuferWasserthal, Senior Vice President Pharmaceuticals, Codexis Incorporated, USA
Hosting Organization
Information Research Center of International Talent, SAFEA
China Medicinal Biotech Association
China Council for the Promotion of International Trade Dalian
Sub-Council
Dalian Association for International Exchange of Personnal
Operating Organization
BIT Life Sciences, Inc.
Foreign Experts Databank
of SAFEA-Dalian Biotechnological and Medical Experts Subdivision
Organization Participated
Kaohsiung Medical University, Taiwan
University of Edinburgh, UK
University of Naples Federico II, Italy
University of Calabria, Italy
Monash University, Australia
University of Shizuoka, Japan
University of Manchester, UK
Chonnam National University, Korea
Syngenta Biotechnology Inc., USA
CRIBIQ, Canada
DSM Biotechnology Center, The Netherlands
CRIBIQ, Canada
Novozymes, Denmark
Technical University of Catalonia, Spain
Instituto de Catalisis. CSIC, Spain
Chr. Hansen A/S, Denmark
Universidade Federal do Ceará, Brazil
PomBioTech GmbH, Germany
University of Sherbrooke, Canada
The New University of Lisbon, Portugal
EPFL, Switzerland
Université Bordeaux 1, France
Wyeth Research, USA
University of Basel, Switzerland
Ohio State University, USA
Codexis, USA
PerkinElmer, USA
CNRS, France
Minho University, Spain
CRA-RPS, Italy
ISEIT/Viseu - Instituto Piaget, Portugal
Colegio de Postgraduados, Mexico
University of Life Sciences, Norway
Ngee Ann Polytechnic, Singapore
Rockefeller University, USA
W42 Consulting GmbH, Sudstr, Germany
University of Nebraska, USA
University of Nottingham, UK
New England Biolabs, USA
Graz University of Technology, Austrian
Université de Bourgogne IUVV, France
Nutreco R & D, The Netherlands
Biomedical Diagnostics Institute, Ireland
International Graduate School of Zittau, Germany
UPC, Spain
John Innes Centre, UK
F. Hoffmann-La Roche Ltd, Switzerland
Yonsei University, Korea
Institute of Biochemistry RAS, Russia
Riken Harima Institute/Spring 8, Japan
Washington University, USA
Chonnam National University, Korea
University of Turku, Finland
Yonsei University, Korea
DSM (CHINA) Ltd., China
Tokushima Bunri University, Japan
Kyoto Institute of Technology, Japan
National Centre for Sensor Research, Ireland
Chonnam National University, Korea
Jeju National University, Korea
Minho University, Portugal
Ajinomoto Co., Inc, Japan
Kao Corporation, Japan
Penn State University, USA
University of California, USA
University of Cergy-Pontoise, France
Korea Atomic Energy Research institute, Korea
Yonsei University, Korea
Louisiana State University, USA
Chonnam National University, Korea
University of Santiago de Compostela, Spain
Idaho State University, USA
Bristol-Myers Squibb Co., USA
Pharmacology, University of Turku, Finland
National University of Singapore, Singapore
Neuroscience and Pain Research, Abbott Laboratories, USA
The New University of Lisbon, Portugal
University of Waterloo, Canada
University Paris 11, France
Okayama University of Science, Japan
VTT, Finland
Universidad de Zaragoza, Spain
University of Duisburg-Essen, Germany
FRS-FNRS, Belgium
Korea Atomic Energy Research Institute, Korea
McGill University, Canada
New England Biolabs, USA
University of Louvain, Belgium
Murray State University, USA
Kyushu University, Japan
Utsunomiya University, Japan
University of Helsinki, Finland
Graz University Technology, Austria
Rockefeller University, USA
Pusan National University, Korea
University of Minho, Portugal
University of Adelaide, Australia
Linkoping University, Sweden
Linkoping University, Sweden
University of Melbourne, Australia
A. N. Bach Institute of Biochemistry, Russia
Molecular and Functional Enzymology, UR4, UPMC, France
National Institute of Standards and Technology, USA
University of Wuerzburg, Institut of organic Chemistry, Germany
the National Institute of Environmental Health Sciences(NIEHS/NIH), USA
De Montfort University, UK
Department of Forest and Forest Products Sciences, Faculty of Agriculture, Kyushu University, Japan
Funai Electric Advanced Applied Technology Research Institute Inc., Japan
Yonsei University, South Korea
Molecular Genetics and Metabolism Laboratory, Germany
Malmoe University, Sweden
Institut of Biochemistry and Biophysics PAS, Poland
METabolic Explorer, France
RWTH Aachen University, Germany
US FDA, USA
Theoretical Chemistry, University of California, USA
Keio University, Japan
Industrial Research Ltd, New Zealand
Ajinomoto Co., Incorporation, Japan
Kemin Industries (Asia) Pte Ltd, Singapore
University of California, USA
University of Tsukuba, Japan
Faculty of Pharmaceutical Sciences, Kyushu University, Japan
The New University of Lisbon, Portugal
Kumamoto University, Japan
CSIC Institute of Catalysis, Spain
Osaka University, Japan
Kansas State University, USA
c-LEcta GmbH, Germany
Rensselaer Polytechnic Institute, USA
New England Biolabs, USA
Kaohsiung Medical University, Taiwan
University of Agriculture, Faisalabad, Pakistan
Kings College London, UK
University of Zurich, Switzerland
R&D China, Novozymes China
NTU, Depardtment of Agricultural Chemistry, Taiwan
Translational Biomedicine (TBM) is an international, open access journal published by iMedPub publishers, Spain. TBM has extensive coverage of all subspecialties of medicine, basic health sciences, molecular biology etc. We invite you to submit your extended/full version of paper based on your presentation in this BIT conference for publication in TBM journal. More information about the Journal is available on our website.
